Legis Daily

Henrietta Lacks Enhancing Cancer Research Act of 2019

USA116th CongressS-946| Senate 
| Updated: 3/28/2019
Chris Van Hollen

Chris Van Hollen

Democratic Senator

Maryland

Cosponsors (7)
Kirsten E. Gillibrand (Democratic)Doug Jones (Democratic)Sheldon Whitehouse (Democratic)Jon Tester (Democratic)Tina Smith (Democratic)Benjamin L. Cardin (Democratic)Susan M. Collins (Republican)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Henrietta Lacks Enhancing Cancer Research Act of 2019 This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 28, 2019
Introduced in Senate
Mar 28, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 5, 2021

Latest Companion Bill Action

HR 116-1966
Signed by President.
  • March 28, 2019
    Introduced in Senate
  • March 28, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • January 5, 2021

    Latest Companion Bill Action

    HR 116-1966
    Signed by President.

Health

Related Bills

  • HR 116-6637: Health Equity and Accountability Act of 2020
  • HR 116-1966: Henrietta Lacks Enhancing Cancer Research Act of 2019
CancerCongressional oversightDrug safety, medical device, and laboratory regulationGovernment studies and investigationsMedical researchMinority healthPublic participation and lobbying

Henrietta Lacks Enhancing Cancer Research Act of 2019

USA116th CongressS-946| Senate 
| Updated: 3/28/2019
Henrietta Lacks Enhancing Cancer Research Act of 2019 This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 28, 2019
Introduced in Senate
Mar 28, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 5, 2021

Latest Companion Bill Action

HR 116-1966
Signed by President.
  • March 28, 2019
    Introduced in Senate
  • March 28, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • January 5, 2021

    Latest Companion Bill Action

    HR 116-1966
    Signed by President.
Chris Van Hollen

Chris Van Hollen

Democratic Senator

Maryland

Cosponsors (7)
Kirsten E. Gillibrand (Democratic)Doug Jones (Democratic)Sheldon Whitehouse (Democratic)Jon Tester (Democratic)Tina Smith (Democratic)Benjamin L. Cardin (Democratic)Susan M. Collins (Republican)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-6637: Health Equity and Accountability Act of 2020
  • HR 116-1966: Henrietta Lacks Enhancing Cancer Research Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerCongressional oversightDrug safety, medical device, and laboratory regulationGovernment studies and investigationsMedical researchMinority healthPublic participation and lobbying